SCHEMBL2353678

SCHEMBL2353678

COCCNC(=O)c1ccc2[nH]cnc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.57
POLB P06746 3/20 0.55
TDP1 Q9NUW8 1/20 0.55
HPGD P15428 4/20 0.53
TP53 P04637 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
MAPK1 P28482 1/20 0.48
CYP2C19 P33261 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
NPC1 O15118 3/20 0.47
KMT2A Q03164 2/20 0.47
RAB9A P51151 2/20 0.47
MEN1 O00255 1/20 0.47
NAMPT P43490 1/20 0.47
TRPA1 O75762 1/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30265199 0.90 HTT (0.71) HTTPOLBTDP1L3MBTL1LMNA
SCHEMBL2354324 0.89 HTT (0.54) HTTPOLBTDP1HPGDTP53
SCHEMBL1534628 0.88 HTT (0.52) HTTPOLBTDP1L3MBTL1LMNA
SCHEMBL30265457 0.86 HTT (0.51) HTTPOLBTDP1HPGDL3MBTL1
Hydrochloric Acid SCHEMBL2355781 0.85 HTT (0.50) HTTPOLBTDP1HPGDL3MBTL1
Hydrochloric Acid SCHEMBL17802677 0.85 HTT (0.50) HTTPOLBTDP1HPGDL3MBTL1
SCHEMBL396107 0.85 POLB (0.53) HTTPOLBTDP1HPGDL3MBTL1
SCHEMBL2351821 0.85 HTT (0.57) HTTPOLBTDP1HPGDTP53
SCHEMBL13373316 0.84 HTT (0.57) HTTPOLBTDP1HPGDL3MBTL1
SCHEMBL2350429 0.84 HTT (0.56) HTTPOLBTDP1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288425-B2 Benzimidazoles AVENTIS PHARMACEUTICALS INC. (US) 2012-10-16 US disclosed
WO-2011103018-A1 SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF HIGH POINT PHARMACEUTICALS, LLC (US) 2011-08-25 WO disclosed